tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

SPRY Stock Latest News

ARS Pharmaceuticals price target raised to $28 from $26 at Raymond James
The FlyARS Pharmaceuticals price target raised to $28 from $26 at Raymond James
5d ago
SPRY
ARS Pharmaceuticals Highlights Success and Plans for 2025
PremiumCompany Announcements
ARS Pharmaceuticals Highlights Success and Plans for 2025
6d ago
8K
SPRY
ARS Pharmaceuticals reports 2025 key strategic priorities
PremiumThe Fly
ARS Pharmaceuticals reports 2025 key strategic priorities
6d ago
SPRY
ARS Pharmaceuticals reports preliminary Q4 neffy revenue $6.5M
PremiumThe Fly
ARS Pharmaceuticals reports preliminary Q4 neffy revenue $6.5M
6d ago
SPRY
ARS Pharmaceuticals files for approval of neffy in Canada, U.K.
PremiumThe Fly
ARS Pharmaceuticals files for approval of neffy in Canada, U.K.
13d ago
SPRY
ARS Pharmaceuticals adds neffy to Commercial national formularies
PremiumThe FlyARS Pharmaceuticals adds neffy to Commercial national formularies
1M ago
SPRY
ARS Pharmaceuticals notes filings for neffy approval in China, Japan, Australia
Premium
The Fly
ARS Pharmaceuticals notes filings for neffy approval in China, Japan, Australia
1M ago
SPRY
ARS Pharmaceuticals files for approval of neffy in China, Japan and Australia
Premium
The Fly
ARS Pharmaceuticals files for approval of neffy in China, Japan and Australia
1M ago
SPRY
ARS Pharmaceuticals announces planned launch of neffyinSchools
PremiumThe Fly
ARS Pharmaceuticals announces planned launch of neffyinSchools
2M ago
SPRY
ARS Pharmaceuticals’ Strong Q3 2024 Highlights
PremiumCompany Announcements
ARS Pharmaceuticals’ Strong Q3 2024 Highlights
2M ago
SPRY
Morning Movers: Spotify rises and Groupon sinks following quarterly results
PremiumThe Fly
Morning Movers: Spotify rises and Groupon sinks following quarterly results
2M ago
AMS
GFF
ARS Pharmaceuticals reports Q3 EPS (20c), consensus (15c)
PremiumThe Fly
ARS Pharmaceuticals reports Q3 EPS (20c), consensus (15c)
2M ago
SPRY
ARS Pharmaceuticals announces agreement with ALK to commercialize neffy
PremiumThe FlyARS Pharmaceuticals announces agreement with ALK to commercialize neffy
2M ago
SPRY
SPRY Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SPRY Earnings this Week: How Will it Perform?
2M ago
SPRY
Cantor Fitzgerald healthcare analyst holds an analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald healthcare analyst holds an analyst/industry conference call
3M ago
SPRY
ARS Pharmaceuticals showcases intranasal epinephrine data at ACAAI meeting
PremiumThe Fly
ARS Pharmaceuticals showcases intranasal epinephrine data at ACAAI meeting
3M ago
SPRY
ARS Pharmaceuticals announces U.S. availability of neffy
PremiumThe Fly
ARS Pharmaceuticals announces U.S. availability of neffy
4M ago
SPRY
ARS Pharmaceuticals submits sNDA to FDA for neffy 1 mg
PremiumThe Fly
ARS Pharmaceuticals submits sNDA to FDA for neffy 1 mg
4M ago
SPRY
ARS Pharmaceuticals launches pre-ordering services for neffy
PremiumThe Fly
ARS Pharmaceuticals launches pre-ordering services for neffy
5M ago
SPRY
ARS Pharmaceuticals announces EC approval for EURneffy
PremiumThe FlyARS Pharmaceuticals announces EC approval for EURneffy
5M ago
SPRY
Medtronic, Palo Alto Networks report quarterly beats: Morning Buzz
Premium
The Fly
Medtronic, Palo Alto Networks report quarterly beats: Morning Buzz
5M ago
AS
BA
Vornado upgraded, JPMorgan downgraded: Wall Street’s top analyst calls
Premium
The Fly
Vornado upgraded, JPMorgan downgraded: Wall Street’s top analyst calls
5M ago
AR
AMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >